Telomerase rebuilds the protective ends of chromosomes that shorten with every cell division

Telomerase rebuilds the protective ends of chromosomes that shorten with every cell division
Image: Intellect (generated)

In short: Each time a cell copies its DNA, the tips of its chromosomes lose a little length. An enzyme called telomerase can add those lost repeats back. Its activity is tightly controlled, and it helps explain both embryonic development and why some cancer cells keep dividing. The story began with a 1984 discovery that later earned a Nobel Prize.

Chromosomes are long strands of DNA, and each end is capped by a region of repeated sequence called a telomere. In humans, the repeat unit is TTAGGG, and some cells carry roughly 1,500 to 2,000 of these repeats at the end of each chromosome. Because copying DNA is imperfect, a short stretch at the tip is not replicated during each division, so the telomere gets a little shorter over time. The telomere acts as a protective cap that helps keep the chromosome intact. Telomerase is a ribonucleoprotein, meaning it combines an RNA molecule with a protein.

Its catalytic core is a protein called telomerase reverse transcriptase, abbreviated TERT, and its RNA serves as a template for building new repeats. The enzyme attaches complementary repeat sequences to the chromosome end, which extends the telomere and offsets the loss that would otherwise accumulate. Telomerase was discovered in 1984 by Elizabeth H. Blackburn and Carol W. Greider, who first called it terminal transferase. They shared the 2009 Nobel Prize in Physiology or Medicine with Jack W. Szostak for their work on telomeres and chromosome maintenance.

Telomerase is active only in certain cells. In germ cells, which give rise to sperm and egg cells, it helps keep chromosomes at full length so genes can be passed on. In embryonic tissues it sets a telomere length that influences how long cells can live, and its activity declines as tissues mature. Many cancer cells reactivate it, which is one reason they can keep dividing. Mutations that disrupt telomerase can cause progressive telomere shortening and are linked to conditions such as pulmonary fibrosis and bone marrow failure.

Researchers are still working out the details. Recent studies in fission yeast suggest that a protein called Replication Protein A helps keep telomerase productively engaged after it is recruited, and that similar interactions may be conserved in humans, though the authors' structural models are predictions rather than settled results. Scientists are exploring telomerase as a possible target for treating disease and as a route to understanding ageing, but these ideas remain research directions rather than established treatments.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-telomerase.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…